Skip to main content

Site notifications

Position statement on the use of tumourigenic cells of human origin for the production of biological and biotechnological medicinal products

We have adopted this International Scientific Guideline - CPMP/BWP/1143/00 

Last updated

Help us improve the Therapeutic Goods Administration site